Radiology in the immune checkpoint inhibitor era

被引：0
|
作者：
Park, Benjamin C. [1 ,4 ]
Johnson, Douglas B. [2 ]
Lewandowski, Robert J. [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Gen Surg, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[3] Northwestern Mem Hosp, Dept Radiol, Chicago, IL 60611 USA
[4] Vanderbilt Univ, Med Ctr, 1161 21st Ave Med Ctr North,D-5203, Nashville, TN 37232 USA
来源：
CLINICAL IMAGING | 2024年 / 107卷
关键词：
Immune checkpoint inhibitors; Interventional oncology; Immune related adverse events; Oncologic imaging;
D O I：
10.1016/j.clinimag.2024.110080
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The field of oncology has undergone rapid changes following the introduction of immunotherapies and biologics. However, these changes have also created new roles for radiology in both diagnosis and treatment. Our article addresses the evolving role of radiology in the immune checkpoint inhibitor era of oncology. With the progression of new immunotherapies for cancer, imaging paradigms and image guided therapy options have changed. Multidisciplinary oncology teams should be aware of these opportunities for collaboration.
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Gastric Cancer in the Era of Immune Checkpoint Blockade
    Figueroa-Protti, Lucia
    Soto-Molinari, Rebeca
    Calderon-Osorno, Melany
    Mora, Javier
    Alpizar-Alpizar, Warner
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [42] Urothelial carcinoma in the era of immune checkpoint inhibitors
    Khalife, Nadine
    Chahine, Claude
    Kordahi, Manal
    Felefly, Tony
    Kourie, Hampig Raphael
    Saleh, Khalil
    IMMUNOTHERAPY, 2021, 13 (11) : 953 - 964
  • [43] obesity and metastatic melanoma: A national perspective from the pre-immune checkpoint inhibitor era.
    Desai, Aakash
    Parmar, Harsh V.
    Hegde, Upendra P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] OUTCOME CHANGE IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA OUTSIDE OF CLINICAL TRIALS FROM THE TYROSINE-KINASE INHIBITOR ERA TO THE IMMUNE CHECKPOINT INHIBITOR ERA
    Ishihara, Hiroki
    Nemoto, Yuki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Kondo, Tsunenori
    Takagi, Toshio
    JOURNAL OF UROLOGY, 2023, 209 : E373 - E373
  • [45] Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy
    Zekeridou, Anastasia
    Lennon, Vanda A.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (09) : 1865 - 1878
  • [46] Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era
    Linette, Gerald P.
    Carreno, Beatriz M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (04) : 286 - 291
  • [47] Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
    Sophia Bylsma
    Karen Yun
    Sandip Patel
    Michael J Dennis
    Current Treatment Options in Oncology, 2022, 23 : 1153 - 1168
  • [48] Immune Checkpoint Inhibitor Related Auto Immune Demyelinating Polyneuropathy
    Mohammed, S. A.
    Hadigal, S.
    Sutchu, S.
    Saleem, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
    Bylsma, Sophia
    Yun, Karen
    Patel, Sandip
    Dennis, Michael J.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (09) : 1153 - 1168
  • [50] Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era
    Gerald P. Linette
    Beatriz M. Carreno
    Current Hematologic Malignancy Reports, 2019, 14 : 286 - 291
12345